Download PDF
Z Gastroenterol 2016; 54(05): 406-408
DOI: 10.1055/s-0042-107486
Editorial
© Georg Thieme Verlag KG Stuttgart · New York

Neue Erkenntnisse zur Rolle der Mikrobiota im kolorektalen Karzinom

Contributor(s):
Sebastian Zeissig
1   Medizinische Klinik I, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden
2   Zentrum für Regenerative Therapien Dresden (CRTD), Technische Universität Dresden, Dresden
,
Jochen Hampe
1   Medizinische Klinik I, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden
› Author Affiliations
Further Information

Publication History

Publication Date:
12 May 2016 (online)

Also available at
    Permissions and Reprints

Kolorektale Karzinome entstehen auf dem Boden somatischer Mutationen. Aktuelle Arbeiten zeigen, dass die Mikrobiota und von ihr aktivierte entzündliche Signalwege entscheidend zum Tumorwachstum beitragen (Peuker et al., Nat Med 2016).

 

  • Referenzen

  • 1 Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767
    CrossrefPubMedGoogle Scholar
  • 2 Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nature immunology 2016; 17: 230-240
    CrossrefPubMedGoogle Scholar
  • 3 Terzic J, Grivennikov S, Karin E et al. Inflammation and colon cancer. Gastroenterology 2010; 138: 2101-2114 e5
    CrossrefPubMedGoogle Scholar
  • 4 West NR, McCuaig S, Franchini F et al. Emerging cytokine networks in colorectal cancer. Nat Rev Immunol 2015; 15: 615-629
    CrossrefPubMedGoogle Scholar
  • 5 Tosolini M, Kirilovsky A, Mlecnik B et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011; 71: 1263-1271
    CrossrefPubMedGoogle Scholar
  • 6 Bollrath J, Phesse TJ, von Burstin VA et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 2009; 15: 91-102
    CrossrefPubMedGoogle Scholar
  • 7 Greten FR, Eckmann L, Greten TF et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitisassociated cancer. Cell 2004; 118 (03) 285-96
    CrossrefPubMedGoogle Scholar
  • 8 Grivennikov S, Karin E, Terzic J et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009; 15: 103-113
    CrossrefPubMedGoogle Scholar
  • 9 Grivennikov SI, Wang K, Mucida D et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012; 491: 254-258
    PubMedGoogle Scholar
  • 10 Schwitalla S, Fingerle AA, Cammareri P et al. Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties. Cell 2013; 152: 25-38
    CrossrefPubMedGoogle Scholar
  • 11 Lee SH, Hu LL, Gonzalez-Navajas J et al. ERK activation drives intestinal tumorigenesis in Apc(min/+) mice. Nat Med 2010; 16: 665-670
    CrossrefPubMedGoogle Scholar
  • 12 Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007; 317: 124-127
    CrossrefPubMedGoogle Scholar
  • 13 Scheeren FA, Kuo AH, van Weele LJ et al. A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis. Nat Cell Biol 2014; 16: 1238-1248
    CrossrefPubMedGoogle Scholar
  • 14 Wang K, Kim MK, Di Caro G et al. Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity 2014; 41: 1052-1063
    CrossrefPubMedGoogle Scholar
  • 15 Kirchberger S, Royston DJ, Boulard O et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 2013; 210: 917-931
    CrossrefPubMedGoogle Scholar
  • 16 Castellarin M, Warren RL, Freeman JD et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22: 299-306
    CrossrefPubMedGoogle Scholar
  • 17 Kostic AD, Gevers D, Pedamallu CS et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22: 292-298
    CrossrefPubMedGoogle Scholar
  • 18 Dejea CM, Wick EC, Hechenbleikner EM et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci USA 2014; 111: 18 321-18326
    CrossrefPubMedGoogle Scholar
  • 19 Wang EL, Qian ZR, Nakasono M et al. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer 2010; 102: 908-915
    CrossrefPubMedGoogle Scholar
  • 20 Kostic AD, Chun E, Robertson L et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013; 14: 207-215
    CrossrefPubMedGoogle Scholar
  • 21 Peuker K, Muff S, Wang J et al. Epithelial calcineurin controls microbiota-dependent intestinal tumor development. Nat Med 2016;
    PubMedGoogle Scholar
  • 22 Duque J, Fresno M, Iniguez MA. Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2. J Biol Chem 2005; 280: 8686-8693
    CrossrefPubMedGoogle Scholar
  • 23 Masuo T, Okamura S, Zhang Y et al. Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen. Cancer Lett 2009; 285: 66-72
    CrossrefPubMedGoogle Scholar
  • 24 Adami J, Gabel H, Lindelof B et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-1227
    CrossrefPubMedGoogle Scholar
  • 25 Dantal J, Hourmant M, Cantarovich D et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomized comparison of two cyclosporin regimens. Lancet 1998; 351: 623-628
    CrossrefPubMedGoogle Scholar
  • 26 Konig A, Fernandez-Zapico ME, Ellenrieder V. Primers on molecular pathways--the NFAT transcription pathway in pancreatic cancer. Pancreatology: official journal of the International Association of Pancreatology (IAP) [et al] 2010; 10: 416-422
    PubMedGoogle Scholar
  • 27 Feng Q, Liang S, Jia H et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nature communications 2015; 6: 6528
    CrossrefPubMedGoogle Scholar